INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 80 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,877 | -64.4% | 47,008 | -72.9% | 0.00% | – |
| Q1 2023 | $27,736 | -77.8% | 173,348 | -22.5% | 0.00% | – |
| Q4 2022 | $124,835 | -61.9% | 223,764 | -18.6% | 0.00% | – |
| Q3 2022 | $328,000 | +42.0% | 274,921 | -24.9% | 0.00% | – |
| Q2 2022 | $231,000 | -18.7% | 366,251 | +46.8% | 0.00% | – |
| Q1 2022 | $284,000 | -92.0% | 249,453 | -84.3% | 0.00% | – |
| Q4 2021 | $3,570,000 | +13.7% | 1,586,958 | +72.8% | 0.00% | – |
| Q3 2021 | $3,141,000 | +80.7% | 918,363 | +58.0% | 0.00% | – |
| Q2 2021 | $1,738,000 | -51.0% | 581,212 | -47.1% | 0.00% | – |
| Q1 2021 | $3,547,000 | +389.9% | 1,097,838 | +220.9% | 0.00% | – |
| Q4 2020 | $724,000 | +1710.0% | 342,132 | +896.2% | 0.00% | – |
| Q3 2020 | $40,000 | +25.0% | 34,344 | -2.4% | 0.00% | – |
| Q2 2020 | $32,000 | +100.0% | 35,197 | +81.0% | 0.00% | – |
| Q1 2020 | $16,000 | -48.4% | 19,441 | -40.4% | 0.00% | – |
| Q4 2019 | $31,000 | -8.8% | 32,628 | -1.4% | 0.00% | – |
| Q3 2019 | $34,000 | -68.5% | 33,100 | -45.4% | 0.00% | – |
| Q2 2019 | $108,000 | -43.8% | 60,600 | -40.7% | 0.00% | – |
| Q1 2019 | $192,000 | +61.3% | 102,128 | +0.9% | 0.00% | – |
| Q4 2018 | $119,000 | -80.0% | 101,200 | -53.9% | 0.00% | – |
| Q3 2018 | $594,000 | +30.0% | 219,352 | -8.3% | 0.00% | – |
| Q2 2018 | $457,000 | -27.9% | 239,102 | -20.7% | 0.00% | – |
| Q1 2018 | $634,000 | +93.9% | 301,641 | +87.1% | 0.00% | – |
| Q4 2017 | $327,000 | +12.4% | 161,261 | -13.1% | 0.00% | – |
| Q2 2017 | $291,000 | +0.3% | 185,574 | +107.1% | 0.00% | – |
| Q1 2017 | $290,000 | -0.3% | 89,600 | -58.3% | 0.00% | – |
| Q4 2016 | $291,000 | +234.5% | 214,861 | +285.7% | 0.00% | – |
| Q3 2016 | $87,000 | +19.2% | 55,700 | +0.9% | 0.00% | – |
| Q2 2016 | $73,000 | 0.0% | 55,200 | +299.5% | 0.00% | – |
| Q1 2016 | $73,000 | -97.2% | 13,816 | -95.8% | 0.00% | – |
| Q4 2015 | $2,601,000 | -21.8% | 331,307 | -15.8% | 0.00% | -100.0% |
| Q3 2015 | $3,326,000 | -21.8% | 393,637 | +1.3% | 0.00% | -50.0% |
| Q2 2015 | $4,254,000 | -17.3% | 388,527 | +5.6% | 0.00% | 0.0% |
| Q1 2015 | $5,142,000 | -61.0% | 367,861 | -52.9% | 0.00% | -66.7% |
| Q4 2014 | $13,179,000 | +19.4% | 780,338 | -5.1% | 0.01% | +50.0% |
| Q3 2014 | $11,034,000 | -1.8% | 822,165 | -6.8% | 0.00% | -20.0% |
| Q2 2014 | $11,239,000 | +92.3% | 882,237 | +79.5% | 0.01% | +66.7% |
| Q1 2014 | $5,843,000 | -67.2% | 491,433 | -61.9% | 0.00% | -62.5% |
| Q4 2013 | $17,801,000 | +117.6% | 1,288,944 | +174.9% | 0.01% | +100.0% |
| Q3 2013 | $8,180,000 | -34.2% | 468,807 | -38.7% | 0.00% | -33.3% |
| Q2 2013 | $12,438,000 | – | 765,388 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,766,508 | $19,826,000 | 2.39% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,286,032 | $2,610,000 | 0.07% |
| Clear Harbor Asset Management, LLC | 153,800 | $312,000 | 0.06% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 219,652 | $445,000 | 0.03% |
| Rock Springs Capital Management LP | 270,000 | $548,000 | 0.02% |
| Alambic Investment Management, L.P. | 77,665 | $158,000 | 0.02% |
| Marshall Wace North America L.P. | 1,173,515 | $2,382,000 | 0.01% |
| Baker Brothers Advisors | 580,400 | $1,178,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $932,000 | 0.01% |
| Intellectus Partners, LLC | 13,000 | $26,000 | 0.01% |